Base de dados : HANSEN Pesquisa : CONTAGEM DE CELULAS SANGUINEAS [Descritor de assunto] Referências encontradas : 5 [refinar] Mostrando: 1 .. 5   no formato [Detalhado]

página 1 de 1

1 / 5

HANSEN

seleciona para imprimir

Id: 18988 Autor: Maslov, A. K; Luzhnova, S. A; Kalyanina, O. V Título: Effects of horseradish root on functional activity of phagocytes, total blood cell count, and state of the liver in mice with experimental leprosy ..- Fonte: s.l; s.n; 2002. 3 p. tab. Resumo: Therapy of experimental leprosy with dried and grated horseradish root administered perorally in a dose of 300 mg/kg mixed food and treatment with purified horseradish peroxidase increased myeloperoxidase activity of blood neutrophils, enhanced antimicrobial functions of phagocytes, decreased leukocytosis, normalized total blood cell count, and produced no adverse effects on the functional state of the liver in mice. (AU). Descritores: CONTAGEM DE CELULAS SANGUINEAS RELACAO DOSE-RESPOSTA A DROGA HANSENIASE/imunol HANSENIASE/fisiopatol FAGOCITOS/ef drogas FAGOCITOS/imunol CAMUNDONGOS ENDOGÂMICOS CBA FIGADO/ef drogas FIGADO/imunol FIGADO/fisiopatol RAIZES DE PLANTA/quim ARMORACIA/quim Limites: ANIMAL CAMUNDONGOS Meio Eletrônico: - . Localização: BR191.1; 09146/s

2 / 5

HANSEN

seleciona para imprimir

Id: 18935 Autor: Halim, N. K. D; Ogbeide, E Título: Haematological alterations in leprosy patients treated with dapsone ..- Fonte: s.l; s.n; Feb. 2002. 3 p. tab. Resumo: OBJECTIVE: To evaluate the haemoglobin concentration (Hb); total white blood cell count (WBC), differential WBC count; platelet count and reticulocyte count in leprosy patients already treated with dapsone. DESIGN: A case-control study. SETTING: Specialist Hospital Ossiomo, which is a Leprosarium and Haematology laboratory, University of Benin Teaching Hospital (UBTH), Nigeria. SUBJECTS: Seventy six leprosy patients (forty males and thirty six females) age range 13-40 years on single dose dapsone. RESULTS: The haemoglobin concentration showed a marked decrease while the reticulocyte count was markedly elevated which was suggestive of haemolytic anaemia. There was also lymphocytosis in patients during pre and post dapsone therapy. CONCLUSION: Leprosy patients on a dosage of 100 mg dapsone, are prone to haemolytic anaemia. Leprosy patients should routinely have their Hb, WBC, platelet count and reticulocyte count determined, while on dapsone therapy in order to ascertain the presence of haemolysis. (AU). Descritores: ANTIMALARICOS/uso terap CONTAGEM DE CELULAS SANGUINEAS ESTUDOS DE CASOS E CONTROLES DAPSONA/uso terap HEMOGLOBINAS/anal HANSENIASE/sangue HANSENIASE/quimioter CONTAGEM DE RETICULOCITOS Limites: HUMANO MASCULINO FEMININO ADULTO SUPPORT, NON-U.S. GOV'T ADOLESCENTE Meio Eletrônico: - . Localização: BR191.1; 09103/s

3 / 5

HANSEN

seleciona para imprimir

Id: 18476 Autor: Queiroz, Regina Helena Costa; Souza, Ana Maria de; Sampaio, Suely Vilela; Melchior Junior, Enzo Título: Biochemical and hematological side effects of clofazimine in leprosy patients ..- Fonte: s.l; s.n; 2002. 4 p. tab. Resumo: Gastrointestinal toxicity and red skin discoloration were the major side effects observed in leprosy patients undergoing long-term treatment with clofazimine (CFZ). Hematological and biochemical alterations have been cited among other side effects; however, their real magnitude and clinical significance at the doses currently employed in therapy have not been sufficiently documented. We therefore investigated the correlation between CFZ plasma concentration and biochemical (transaminases, bilirubins, alkaline phosphatase, gamma-glutamyltransferase, amylase, urea, creatinine, and potassium plasma levels) as well as hematological changes blood and reticulocyte counts, osmotic fragility, detection of Heinz bodies and methemoglobinemia (MHM), following in two regimes of treatment: CFZ as a single drug and CFZ as part of multidrug (MDT) therapy, in combination with dapsone and rifampicin. MHM and hemolytic anemia were detected in the MDT group only. Eosinophilia was found in patients of either group. Determination of hepatic, pancreatic and renal biochemical parameters showed rare, occasional changes of apparently no clinical significance. We conclude that CFZ is a generally well tolerated and safe drug when given as a daily dose of 50mg, which is currently used in leprosy patients. (AU). Descritores: CONTAGEM DE CELULAS SANGUINEAS CLOFAZIMINA/admin CLOFAZIMINA/ef adv CLOFAZIMINA/uso terap DAPSONA/admin DAPSONA/ef adv DAPSONA/uso terap QUIMIOTERAPIA COMBINADA HANSENOSTATICOS/admin HANSENOSTATICOS/ef adv HANSENOSTATICOS/uso terap HANSENIASE/sangue HANSENIASE/quimioter RIFAMPINA/admin RIFAMPINA/ef adv RIFAMPINA/uso terap Limites: SUPPORT, NON-U.S. GOV'T FEMININO HUMANO MASCULINO Meio Eletrônico: - . Localização: BR191.1; 08998/s

4 / 5

HANSEN

seleciona para imprimir

Id: 17918 Autor: Levine, Peter H; Weintraub, Lewis R Título: Pseudoleukemia during recovery from dapsone-induced agranulocytosis ..- Fonte: s.l; s.n; may 1968. 6 p. ilus, graf. Resumo: The case presented here illustrates how convincingly the recovery from agranulocytosis may mimic acute leukemia in both the peripheral blood and the bone marrow. The development of a leukemia-like syndrome in any patient who has been exposed to a drug known to cause agranulocytosis should raise the question of pseudoleukemia. Repeated bone marrow aspirations and daily observation of changes in peripheral blood parameters will help prevent needless exposure to myelossuppressive agents. The experience with this case makes mandatory an awareness of agranulocytosis as a side effect of dapsone.(AU). Descritores: AGRANULOCITOSE/ind quim AGRANULOCITOSE/diag CONTAGEM DE CELULAS SANGUINEAS CELULAS DA MEDULA OSSEA DAPSONA DIAGNOSTICO DIFERENCIAL CONTAGEM DE LEUCOCITOS DERMATOPATIAS/quimioter Meio Eletrônico: - . Localização: BR191.1; 01860/s

5 / 5

HANSEN

seleciona para imprimir

Id: 14993 Autor: Maslov, A. K; Luzhnova, S. A Título: Effects of peroxidase therapy on functional state of the liver and phagocytes and blood cell counts in mice with experimental leprosy ..- Fonte: s.l; s.n; 2000. 5 p. ilus, tab, graf. Descritores: HANSENIASE HANSENIASE FIGADO FIGADO CONTAGEM DE CÉLULAS SANGUINEAS PEROXIDASE DO RABANO SILVESTRE MICROSCOPIA ELETRONICA PEROXIDASE FAGOCITOS FAGOCITOS CAMUNDONGOS ENDOGAMICOS CBA Limites: ANIMAL CAMUNDONGOS Localização: BR191.1; 07330/s

---

página 1 de 1

Refinar a pesquisa

Base de dados : HANSEN

Formulário avançado

Pesquisar por : Formulário livre

		Pesquisar	no campo
1			PalavrasPalavras do títuloPalavras do resumoAutorAutor institucionalDescritor de assuntoLimitesIdiomaPaís, ano de publicaçãoRevistaTipo de literaturaNível bibliográficoMonografia em sérieTipo de publicaçãoConferênciaIdentificador únicoLocalizaçãoSuporte eletrônicoData de entradaTipo de registro
2	and or and not		PalavrasPalavras do títuloPalavras do resumoAutorAutor institucionalDescritor de assuntoLimitesIdiomaPaís, ano de publicaçãoRevistaTipo de literaturaNível bibliográficoMonografia em sérieTipo de publicaçãoConferênciaIdentificador únicoLocalizaçãoSuporte eletrônicoData de entradaTipo de registro
3	and or and not		PalavrasPalavras do títuloPalavras do resumoAutorAutor institucionalDescritor de assuntoLimitesIdiomaPaís, ano de publicaçãoRevistaTipo de literaturaNível bibliográficoMonografia em sérieTipo de publicaçãoConferênciaIdentificador únicoLocalizaçãoSuporte eletrônicoData de entradaTipo de registro

Search engine: iAH v2.6.1 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information